The diagnosis of symptomatic CA-UTI is often a diagnosis of exclusion [ 4, 24].
Catheter associated bacteriuria is very common and there is a need to differentiate symptomatic CA-UTI from asymptomatic bacteriuria (CA-ASB) to rationalise antibiotic usage.
Patients who progressed according to RECIST criteria within 7 days following symptomatic or CA-125 progressive disease (PD) were considered to have RECIST first PD.
The time to RECIST or symptomatic progression following CA-125 elevation was evaluated by censoring patients at the date of first new treatment or date last known alive.
Drinking something like Pedialyte might make sense as a symptomatic cure, but I can't endorse any of that.
Following approval by the Ohio State University Institutional Review Board, patients enrolled in our study were previously diagnosed with PHPT and had symptomatic hypercalcemia (serum total Ca > 10.0 mg/dL), elevated PTH (>72 pg/mL), and a single MIBI-avid parathyroid adenoma evident on preoperative MIBI imaging.
In all, 832 patients (85%) progressed, with 60% experiencing a first radiological progression, 10% symptomatic progression, and 28% CA-125 progression without evidence of radiological or symptomatic progression.
Participants in our study with symptomatic OH may have impaired CA and more extreme changes in CBF resulting in orthostatic symptoms.
CA-UTI is the most common adverse event associated with indwelling urinary catheter use (Table 1), although only a small proportion of acute care facility residents with CA-ASB develop symptomatic infection [ 10].
CA-125 and/or symptomatic progression was also observed within 7 days before or after RECIST progression in 217 (44%) and 51 (10%) patients, respectively.
Similarly, patients who had symptomatic PD within 3 days following CA-125 PD without RECIST PD were considered to have symptomatic first PD.
